Internal Medicine, Hematology & Oncology · New York, NY
NPI
1306003793
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1275 York Ave, Box 8
New York, NY, 10065
Phone (646) 888-4626
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
803 services
Medicare patients, 2024
175
Average age 74
Drug cost, 2024
$2.4M
714 prescriptions
Company payments, 2025
$35K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James Harding was code 99214 (office e&m - established), 679 times for 141 patients. In total James Harding billed 803 services in 15 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 679 | 141 | $86.37 | $59K |
| 99205 Office E&M - New | Office | 42 | 42 | $162.33 | $6,818 |
By year: 2022 $71K for 774 services; 2023 $72K for 794 services; 2024 $73K for 803 services.
Medicare prescription drug claims, 2024
In 2024, the drug James Harding prescribed most often to Medicare patients was Xarelto (Rivaroxaban), with 51 prescriptions and refills. In total James Harding wrote 714 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xarelto Rivaroxaban | 51 | 53 | 15 | $31K |
| Lenvima Lenvatinib Mesylate | 51 | 51 | Under 11 | $1.2M |
| Pantoprazole Sodium Generic | 50 | 68 | 22 | $539 |
| Ondansetron Hcl Generic | 47 | 47 | 36 | $446 |
| Dexamethasone Generic | 29 | 29 | 20 | $318 |
| Oxycodone Hcl Generic | 29 | 29 | 18 | $233 |
| Ursodiol Generic | 28 | 56 | Under 11 | $2,538 |
| Spironolactone Generic | 25 | 33 | Under 11 | $200 |
| Pemazyre Pemigatinib | 23 | 23 | Under 11 | $449K |
| Furosemide Generic | 22 | 28 | 12 | $35.96 |
| Amlodipine Besylate Generic | 21 | 39 | Under 11 | $31.04 |
| Cabometyx Cabozantinib S-Malate | 21 | 21 | Under 11 | $357K |
| Creon Lipase/Protease/Amylase | 13 | 18 | Under 11 | $26K |
| Enoxaparin Sodium Generic | 13 | 15 | Under 11 | $3,770 |
| Prednisone Generic | 12 | 12 | Under 11 | $30.56 |
Brand drugs: - claims; generic drugs: 514 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Harding $35K ($35K in general payments such as food, travel and fees) from 10 companies. The largest payer was Jazz Pharmaceuticals Inc. with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.